Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews

被引:42
|
作者
Rodriguez-Torres, Edgardo [1 ,2 ]
Gonzalez-Perez, Margarita M. [3 ]
Diaz-Perez, Clemente [4 ,5 ]
机构
[1] Univ Puerto Rico, Inst Stat, 501 Ave Univ,Suite 1525, Rio Piedras, PR 00925 USA
[2] Univ Puerto Rico, CIS, 501 Ave Univ,Suite 1525, Rio Piedras, PR 00925 USA
[3] Univ Puerto Rico, Sch Med Lib, Med Sci Campus Ret, Rio Piedras, PR USA
[4] Univ Puerto Rico, Sch Med, Med Sci Campus, Rio Piedras, PR USA
[5] Univ Puerto Rico, Hispan Alliance Clin & Translat Res, Med Sci Campus, Rio Piedras, PR USA
关键词
Clinical trials participation; Clinical trials recruitment; Clinical trials enrollment; Barriers to clinical trial participation; Facilitators to clinical trial participation; Overview of reviews; HIV VACCINE TRIALS; RANDOMIZED CONTROLLED-TRIALS; PATIENT PARTICIPATION; UNDERREPRESENTED POPULATIONS; HEALTHY-VOLUNTEERS; AFRICAN-AMERICANS; ETHNIC-MINORITIES; DECISION-MAKING; CANCER TRIAL; RECRUITMENT;
D O I
10.1016/j.conctc.2021.100829
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The demand for clinical trial participants is today one of the highest it has ever been and continues to increase. At the same time, subject recruitment continues to be problematic and the major reason for clinical trial premature terminations. The literature on clinical trial recruitment, which spans several decades and includes hundreds of studies, has an abundance of findings that can be synthesized by way of an overview to provide a well-informed and complete picture of the factors that determine subject participation. Objectives: An overview of the systematic reviews that report barriers and facilitators to clinical trial participation was conducted. The extracted data were synthesized, and a thematic framework of the factors that affect subject participation in clinical trials was developed. The overview extended across medical subjects and demographics. Methods: Thirty reviews that complied with the inclusion criteria were included. These reviews covered 753 relevant primary studies and reported 881 barriers and facilitators. The barriers and facilitators were thematically synthesized and a thematic framework of 20 themes was developed. The quality of the included reviews was assessed and reported. Main results: Several opportunities to increase clinical trial participation, by developing interventions and changing the trial design, derived from an analysis of the thematic framework. That analysis also showed that most of the 20 themes operate mainly as a barrier or as a facilitator, and that most have an effect across medical subjects. As to the quality elements assessed, some reviews complied almost fully but most only partially.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Barriers and facilitators to enrollment in pediatric clinical trials: an overview of systematic reviews
    Bencheva, Veronika
    Mann, Nina-Kristin
    Rombey, Tanja
    Pieper, Dawid
    Schmiedl, Sven
    SYSTEMATIC REVIEWS, 2024, 13 (01)
  • [2] BARRIERS AND FACILITATORS TO PARTICIPATION OF MINORITIES IN CLINICAL TRIALS
    Schmotzer, Geri L.
    ETHNICITY & DISEASE, 2012, 22 (02) : 226 - 230
  • [3] Perceived barriers and facilitators of participation in clinical trials for Duchenne and Becker muscular dystrophy
    Peay, H. L.
    Scharff, H.
    Biesecker, B. B.
    Wilfond, B. S.
    Johnson, J.
    Escolar, D. M.
    Bowie, J.
    Nagaraju, K.
    Piacentino, J.
    Tibben, A.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 912 - 912
  • [4] An Overview of Reviews on Interprofessional Collaboration in Primary Care: Barriers and Facilitators
    Rawlinson, Cloe
    Carron, Tania
    Cohidon, Christine
    Arditi, Chantal
    Hong, Quan Nha
    Pluye, Pierre
    Peytremann-Bridevaux, Isabelle
    Gilles, Ingrid
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2021, 21 (02):
  • [5] Barriers to participation in clinical trials
    Clayton, Harriet
    Grant, Pauline
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 27 - 27
  • [6] Barriers and Facilitators to Participation in Clinical Trials Related to Familial Frontotemporal Dementia: A Qualitative Study
    Zammitt, David
    Brotherhood, Emilie V.
    Fearn, Caroline
    Greaves, Caroline
    Hayes, Ollie
    Harding, Emma
    Lykourgos, Madalena
    Rohrer, Jonathan D.
    Stott, Josh
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2024, 12 (11):
  • [7] Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews
    Farhoudian, Ali
    Razaghi, Emran
    Hooshyari, Zahra
    Noroozi, Alireza
    Pilevari, Azam
    Mokri, Azarakhsh
    Mohammadi, Mohammad Reza
    Malekinejad, Mohsen
    SUBSTANCE ABUSE-RESEARCH AND TREATMENT, 2022, 16
  • [8] Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews
    Farhoudian, Ali
    Razaghi, Emran
    Hooshyari, Zahra
    Noroozi, Alireza
    Pilevari, Azam
    Mokri, Azarakhsh
    Mohammadi, Mohammad Reza
    Malekinejad, Mohsen
    SUBSTANCE ABUSE-RESEARCH AND TREATMENT, 2022, 16
  • [9] Perceptions of barriers and facilitators to participation in clinical trials in HIV-Positive latinas:: A pilot study
    Zuniga, Maria Luisa
    Blanco, Estela
    Martinez, Paulina
    Strathdee, Steffanie A.
    Gifford, Allen L.
    JOURNAL OF WOMENS HEALTH, 2007, 16 (09) : 1322 - 1330
  • [10] Motivation and barriers to participation in clinical trials
    Gaul, Charly
    Schmidt, Thomas
    Helm, Juergen
    Hoyer, Heike
    Haerting, Johannes
    MEDIZINISCHE KLINIK, 2006, 101 (11) : 873 - 879